CTSA K12 Program at the University of Michigan
CTSA K12 Program at the University of Michigan
批准号:
10621008
负责人:
VICKI L ELLINGROD
金额:
$162.0万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-04-01 至 2028-03-31
关键词:
AccelerationAddressAdvocateAreaClinicalClinical ResearchCommunitiesCompetency-Based EducationEducational CurriculumEvaluationExtramural ActivitiesFacultyFeedbackFundingGenomicsHealthHumanInfluentialsInstitutionLeadMentored Clinical Scientist Development ProgramMentorsMichiganOutcomePaperPatternPharmaceutical PreparationsPoliciesPolicy ResearchPostdoctoral FellowPreparationProgram DevelopmentResearchResearch Project GrantsResearch SupportResearch TrainingScienceScientistSecureSocial NetworkTimeTrainingTranslational ResearchTranslationsUniversitiesWorkcareercareer developmentfortificationhealth disparityinnovationmultidisciplinaryopioid epidemicprogramssocial mediasuccesstranslational research program
中文摘要
项目摘要/摘要
密歇根临床与健康研究所(MICHR)的职业发展计划提供了
对90多种不同的创新和有效的临床和转化性研究进行培训和支持
自2017年以来,多学科科学家继续取得重大科学发现。完毕
在过去的15年里,我们的校友撰写了3300多篇科学论文,产生了超过
在社交媒体上发表了5.3万条评论,并被纳入240份政策文件。他们也收到了超过
4亿美元的研究拨款支持。我们的学者已经成为翻译科学的领导者和有影响力的人
为那些在国家层面领导翻译研究项目的人提供指导。他们的
从基本药物到基本药物,这些努力为解决美国一些最令人头疼的健康挑战做出了贡献
以及基因组发现,用于解决健康差距和阿片类药物危机的政策研究。MICHR的K12
计划通过我们强大的评估平台不断得到加强,该平台整合了关键反馈
来自多个利益相关者团体,以实施以能力为基础的新教育倡议。我们杰出的
所有经过导师培训的项目教职员工,欢迎我们的K12学者加入他们的高度
成功的研究项目(超过9000万美元的外部资金)。新的MICHR K12计划将
每年支持11名高级博士后研究员或早期教员级别的学者,通过提供新的
支持机构转型的方案倡议,涉及往往看不见但无处不在的
不成比例地改变那些在其领域未被充分代表的人的职业生涯的模式(即,隐藏的
课程)。通过以下主题重点领域,我们将为每名K12学者提供两到三次的支持
多年来,他们在我们的计划中努力获得翻译研究的独立性:1)强化
在翻译科学和研究方面进行精确准备的职业轨迹;2)通过以下方式加速翻译
让学者做好充分利用科学社交网络的准备;3)让学者成为多才多艺的沟通者
他们领导着有效的研究团队,成为科学倡导者。我们的预期结果是K12计划
这更好地为学者在进行翻译研究和研究方面的长期成功做好准备和装备
科学,特别是在离开我们的计划之后,因为他们获得了外部研究支持。此外,这些
努力将推动普遍模式的改变,这种模式可以改变学者们的长期成功,因为他们努力
成为各自领域的翻译科学领导者。这些努力还将使我们能够延续MICHR的遗产
在影响人类健康的不同研究科学界建立强大的领导者。
英文摘要
Project Summary/Abstract
The Michigan Institute for Clinical & Health Research (MICHR) career development programs have provided
innovative and impactful clinical and translational research training and support to more than 90 diverse
multidisciplinary scientists since 2017 who have continued on to make important scientific discoveries. Over
the past 15 years our alumni have authored more than 3300 scientific papers that have generated more than
53,000 social media remarks and been included in 240 policy documents. They have also received more than
$400M in research grant support. Our scholars have emerged as translational science leaders and influential
mentors for those following their path as they lead translational research programs at the national level. Their
efforts have contributed to solving some of the nation's most vexing health challenges ranging from basic drug
and genomic discovery to policy research addressing health disparities and the opioid crisis. MICHR's K12
program is continually strengthened through our robust evaluation platform, which integrates critical feedback
from multiple stakeholder groups to implement new competency-based educational initiatives. Our outstanding
program faculty, all of which have undergone mentor training, welcome our K12 scholars into their highly
successful research programs (more than $90M in extramural funds). The new MICHR K12 program will
support 11 scholars annually, who are at a senior postdoctoral fellow or early faculty level, by providing new
programmatic initiatives to support institutional transformation regarding the often invisible but pervasive
patterns that disproportionately alter careers for those underrepresented in their fields (i.e., the hidden
curriculum). Through the following areas of thematic focus, we will support each K12 scholar for two to three
years as they work to gain translational research independence during their time in our program: 1) Fortify
career trajectories with precision preparation in translational science and research; 2) Accelerate translation by
preparing scholars to best utilize scientific social networks; 3) Prepare scholars to be versatile communicators
who lead effective research teams and become science advocates. Our expected outcome is a K12 program
that better prepares and equips scholars for long-term successes in conducting translational research and
science, particularly after leaving our program as they secure external research support. Moreover, these
efforts will motivate change in pervasive patterns that can alter scholars' long-term success as they work to
become translational science leaders in their fields. These efforts will also allow us to continue MICHR's legacy
of building strong leaders within diverse research scientific communities that impact human health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CTSA Predoctoral T32 at the University of Michigan
-
批准号:10620888
-
项目类别:
-
资助金额:$54.13万
-
财政年份:2023
-
负责人:VICKI L ELLINGROD
-
依托单位:
Institutional Career Development Core
-
批准号:9414515
-
项目类别:
-
资助金额:$138.29万
-
财政年份:2017
-
负责人:VICKI L ELLINGROD
-
依托单位:
Development, Implementation and AssessMent of Novel Training in Domain-based Competencies (DIAMOND)
-
批准号:9319951
-
项目类别:
-
资助金额:$81.62万
-
财政年份:2017
-
负责人:VICKI L ELLINGROD
-
依托单位:
Institutional Career Development Core
-
批准号:10116515
-
项目类别:
-
资助金额:$138.29万
-
财政年份:2017
-
负责人:VICKI L ELLINGROD
-
依托单位:
Antipsychotic and Folate Pharmacogenetics - Gender Supplement
-
批准号:8797754
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Antipsychotic and Folate Pharmacogenetics
-
批准号:8578175
-
项目类别:
-
资助金额:$43.9万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Folate Pharmacogenomics and Risk of Atypical Antipsychtoic Metabolic Side Effects
-
批准号:8019472
-
项目类别:
-
资助金额:$33.43万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Folate Pharmacogenomics and Risk of Atypical Antipsychtoic Metabolic Side Effects
-
批准号:8213443
-
项目类别:
-
资助金额:$33.42万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Antipsychotic and Folate Pharmacogenetics
-
批准号:8884655
-
项目类别:
-
资助金额:$38.22万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Antipsychotic and Folate Pharmacogenetics
-
批准号:9098787
-
项目类别:
-
资助金额:$38.22万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Folate Pharmacogenomics and Risk of Atypical Antipsychtoic Metabolic Side Effects
-
批准号:7760595
-
项目类别:
-
资助金额:$33.78万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Antipsychotic and Folate Pharmacogenetics
-
批准号:9301028
-
项目类别:
-
资助金额:$38.22万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Antipsychotic and Folate Pharmacogenetics
-
批准号:8705013
-
项目类别:
-
资助金额:$38.22万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Antipsychotic and Folate Pharmacogenetics
-
批准号:8931314
-
项目类别:
-
资助金额:$7.78万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Folate Pharmacogenomics and Risk of Atypical Antipsychtoic Metabolic Side Effects
-
批准号:7617851
-
项目类别:
-
资助金额:$33.79万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Genetics of Antipsychotic Metabolism
-
批准号:7040750
-
项目类别:
-
资助金额:$0.13万
-
财政年份:2004
-
负责人:VICKI L ELLINGROD
-
依托单位:
Genetics of Antipsychotic Metabolism
-
批准号:6905615
-
项目类别:
-
资助金额:$14.71万
-
财政年份:2001
-
负责人:VICKI L ELLINGROD
-
依托单位:
Genetics of Antipsychotic Metabolism
-
批准号:6529325
-
项目类别:
-
资助金额:$15.09万
-
财政年份:2001
-
负责人:VICKI L ELLINGROD
-
依托单位:
Genetics of Antipsychotic Metabolism
-
批准号:6649155
-
项目类别:
-
资助金额:$15.38万
-
财政年份:2001
-
负责人:VICKI L ELLINGROD
-
依托单位:
Genetics of Antipsychotic Metabolism
-
批准号:6366012
-
项目类别:
-
资助金额:$14.72万
-
财政年份:2001
-
负责人:VICKI L ELLINGROD
-
依托单位:
海外基金